Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie A Schultz

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Nature Medicine|January 22, 2019
Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's diseaseOliver Preische, Stephanie A Schultz, Anja Apel, et al.
Molecular Neurodegeneration|December 19, 2023
Advanced structural brain aging in preclinical autosomal dominant Alzheimer diseasePeter R Millar, Brian A Gordon, Julie K Wisch, et al.
Nature Communications|November 18, 2024
Comparative neurofilament light chain trajectories in CSF and plasma in autosomal dominant Alzheimer's diseaseAnna Hofmann, Lisa M Häsler, Marius Lambert, et al.
The Lancet. Neurology|January 22, 2022
Variant-dependent heterogeneity in amyloid β burden in autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analyses of an observational studyJasmeer P Chhatwal, Stephanie A Schultz, Eric McDade, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
BiomarkersJulie K Wisch, Nicole S McKay, Matthew D Zammit, et al.
Neurobiology of Disease|June 12, 2020
Serum neurofilament light chain levels are associated with white matter integrity in autosomal dominant Alzheimer's diseaseStephanie A Schultz, Jeremy F Strain, Adedamola Adedokun, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 28, 2025
Resistance and resilience to Alzheimer's disease in Down syndromeRory Boyle, Elouise A Koops, Beau Ances, et al.
JAMA Neurology|October 16, 2023
Etiology of White Matter Hyperintensities in Autosomal Dominant and Sporadic Alzheimer DiseaseZahra Shirzadi, Stephanie A Schultz, Wai-Ying W Yau, et al.
Acta Neuropathologica|June 3, 2025
Immunohistochemical evaluation of a trial of gantenerumab or solanezumab in dominantly inherited Alzheimer diseaseCharles D Chen, Erin E Franklin, Yan Li, et al.
Aging Cell|June 9, 2023
Location of pathogenic variants in PSEN1 impacts progression of cognitive, clinical, and neurodegenerative measures in autosomal-dominant Alzheimer's diseaseStephanie A Schultz, Zahra Shirzadi, Aaron P Schultz, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Nature Medicine|January 22, 2019
Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's diseaseOliver Preische, Stephanie A Schultz, Anja Apel, et al.
Molecular Neurodegeneration|December 19, 2023
Advanced structural brain aging in preclinical autosomal dominant Alzheimer diseasePeter R Millar, Brian A Gordon, Julie K Wisch, et al.
Nature Communications|November 18, 2024
Comparative neurofilament light chain trajectories in CSF and plasma in autosomal dominant Alzheimer's diseaseAnna Hofmann, Lisa M Häsler, Marius Lambert, et al.
The Lancet. Neurology|January 22, 2022
Variant-dependent heterogeneity in amyloid β burden in autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analyses of an observational studyJasmeer P Chhatwal, Stephanie A Schultz, Eric McDade, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
BiomarkersJulie K Wisch, Nicole S McKay, Matthew D Zammit, et al.
Neurobiology of Disease|June 12, 2020
Serum neurofilament light chain levels are associated with white matter integrity in autosomal dominant Alzheimer's diseaseStephanie A Schultz, Jeremy F Strain, Adedamola Adedokun, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 28, 2025
Resistance and resilience to Alzheimer's disease in Down syndromeRory Boyle, Elouise A Koops, Beau Ances, et al.
JAMA Neurology|October 16, 2023
Etiology of White Matter Hyperintensities in Autosomal Dominant and Sporadic Alzheimer DiseaseZahra Shirzadi, Stephanie A Schultz, Wai-Ying W Yau, et al.
Acta Neuropathologica|June 3, 2025
Immunohistochemical evaluation of a trial of gantenerumab or solanezumab in dominantly inherited Alzheimer diseaseCharles D Chen, Erin E Franklin, Yan Li, et al.
Aging Cell|June 9, 2023
Location of pathogenic variants in PSEN1 impacts progression of cognitive, clinical, and neurodegenerative measures in autosomal-dominant Alzheimer's diseaseStephanie A Schultz, Zahra Shirzadi, Aaron P Schultz, et al.
Pageof 6